JHOP - June 2021 Vol 11, No 3

Ellen Madarang, PharmD, BCOP; Leslie Gallardo, PharmD, BCPS; Terrence Bradley, MD

Denosumab for First-Line Treatment of Hypercalcemia Associated with Malignancy: Retrospective Analysis

Katherine P. Morgan, PharmD, BCOP, CPP; Yujiao Sun, PharmD; Allison Deal; Jared Weiss, MD; Amber Cipriani, PharmD, BCOP

Jessica M. Tran, PharmD, BCPS; Ni-Chi Wu, PharmD, BCOP, BCPS; Rajkumar J. Sevak, PhD, RPh; Pankaj Gupta, MD, FACP

Pharmacy Resident–Led Medication Reconciliation and Patient Education Service in Adults with Leukemia Receiving Anticancer Oral Agents: A Pilot Study

Lily Y. Jia, PharmD, BCOP; Jessie Signorelli, PharmD, BCOP; Samantha O. Luk, PharmD, BCOP; E. Bridget Kim, PharmD, BCPS, BCOP; Gayle C. Blouin, PharmD, BCOP

Corrections

From the Literature

Daily Aspirin Does Not Lower Colorectal Cancer Risk When Started After Age 70

Adjuvant Nivolumab Therapy Prolongs Disease-Free Survival in Patients with Esophageal Cancer

New Data Reveal Mismatched Need and Supply of Oncology Physicians and Pharmacists in America

FDA Updates

Lumakras First FDA-Approved Therapy for Advanced or Metastatic NSCLC with KRAS G12C Mutation

Rybrevant First FDA-Approved Therapy for NSCLC with EGFR Exon 20 Insertion Mutations

Zynlonta First FDA-Approved CD19-Directed Therapy for Large B-Cell Lymphoma

Jemperli First FDA-Approved Immunotherapy for Advanced Endometrial Cancer with dMMR Biomarker

Keytruda Received FDA Approval for First-Line Treatment of HER2-Positive Advanced Gastric Cancer

Opdivo First FDA-Approved Immunotherapy for First-Line Treatment of Advanced Gastric Cancer

Trodelvy Receives New Indication for Advanced Urothelial Cancer

Sarclisa Receives New Indication for Relapsed or Refractory Multiple Myeloma

Symptom Management Overview

How I Treat Anemia Associated with Lower-Risk Myelodysplastic Syndromes

Brenna Rowen, PharmD, BCOP

HOPA Highlights

The Impact of Racial Disparities in Cancer Care: Racism a Risk Factor for Poor Clinical Outcomes

Eliminating Structural Racism in Oncology Pharmacy: Individual and Organizational Responsibility

New Opportunities for Pharmacists in Clinical Trials and Drug Development After COVID-19

Immunotherapy Continues to Transform the Treatment Landscape for Advanced Non–Small-Cell Lung Cancer

Cancer Pain Management and the Opioid Conundrum: Optimizing Outcomes, Minimizing Risks

Managing Thromboembolism in Patients with Cancer: Which Are the Preferred Anticoagulants?